ASDr. Ahmed ShihabConsultant Anesthesiologist – Baghdad عربي

Intravenous Induction Agents in Anaesthesia

Topic notes · Basic Sciences · Anaesthetic drugs

Intravenous induction agents are an indispensable cornerstone for starting general anaesthesia effectively and smoothly in a wide range of patients. This educational article, directed at students of the Anaesthesia Challenge on the Dr Ahmed Shihab platform at MAQ Academy, reviews the pharmacological properties of these compounds precisely and concisely.

Propofol and Thiopentone

Propofol acts by increasing Cl- conductance associated with GABA-A receptors, and the induction dose for adults is set at 1.5-2.5 mg/kg with an onset between 30-45 s and a duration of effect ranging between 4-7 min. Propofol causes apnoea and pain on injection and a fall in blood pressure (hypotension) due to vasodilatation and negative inotropy, but it is distinguished by being antiemetic and non-cumulative. In contrast, Thiopentone also acts on GABA-A at a dose of 2-6 mg/kg and an onset between 20-30 s, but it is considered a cumulative drug with repeated doses, and it is absolutely contraindicated in acute porphyria.

Ketamine and Its Special Features

Ketamine is an outlier from the rest of the group as an NMDA antagonist and has no action on GABA-A receptors, and its dose is given at 1-2 mg/kg IV. It is distinguished by unique effects including producing profound analgesia and increasing both BP and HR, and it also leads to bronchodilation with minimal respiratory depression and preserved laryngeal reflexes. However, its use is associated with a rise in ICP and the appearance of disturbances including hallucinations/emergence delirium.

Etomidate and Midazolam

Etomidate acts on GABA-A receptors and its dose ranges between 0.2-0.3 mg/kg, and it is notable for being extremely haemodynamically stable, but it causes suppression of adrenocortical steroid synthesis and is also accompanied by pain on injection and involuntary movement. Midazolam, on the other hand, is a benzodiazepine that acts specifically at the GABA-A alpha/gamma interface and its dose ranges between 0.1-0.3 mg/kg; it provides an anticonvulsant effect in addition to amnesia, noting that the compound hydroxymidazolam accumulates in patients with renal impairment.

Key points
  • Propofol is characterised by antiemetic properties and non-cumulative behaviour at a dose of 1.5-2.5 mg/kg, while causing hypotension and apnoea.
  • Thiopentone is cumulative at a dose of 2-6 mg/kg and is categorically contraindicated in acute porphyria.
  • Ketamine acts as an NMDA antagonist to give profound analgesia and raises BP, HR and ICP while causing bronchodilation.
  • Etomidate achieves haemodynamically stable conditions at a dose of 0.2-0.3 mg/kg but suppresses adrenocortical steroid synthesis.
  • Midazolam provides an anticonvulsant effect and amnesia, with accumulation of hydroxymidazolam in renal impairment.

Sources

  • Clinical Anaesthesia: Lecture Notes, p. 48
  • Smith and Aitkenhead's Textbook of Anaesthesia, pp. 66–70
  • Smith and Aitkenhead's Textbook of Anaesthesia, p. 431
  • Smith and Aitkenhead's Textbook of Anaesthesia, p. 84

Test yourself: 5 questions on this topic and many more →

Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.